← Back to Clinical Trials
Recruiting NCT07478510

NCT07478510 Cognitive Evaluation of Patients With Eating Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07478510
Status Recruiting
Phase
Sponsor Istituti Clinici Scientifici Maugeri SpA
Condition ARFID
Study Type OBSERVATIONAL
Enrollment 84 participants
Start Date 2024-11-26
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Go/No-goIATWCST

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 84 participants in total. It began in 2024-11-26 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this cross - sectional observational study is to improve understanding of the psychological and cognitive characteristics of Feeding and Eating Disorders (FEDs), a group of conditions that represent a growing public health concern due to their significant impact on physical health, emotional well-being, and everyday functioning. Within this broader diagnostic category, particular attention is given to Avoidant/Restrictive Food Intake Disorder (ARFID), a diagnosis introduced in the DSM-5 and still relatively underexplored compared to other feeding and eating disorders. Despite its clinical relevance, ARFID remains less well understood in terms of its underlying cognitive and psychological mechanisms. Individuals with ARFID often experience severe food avoidance or restriction that is not driven by weight or shape concerns, but rather by sensory sensitivities, fear of negative consequences of eating, or a lack of interest in food. For this reason, investigating ARFID can offer important insights into the diversity of mechanisms involved in feeding and eating disorders as a whole. The study has two main objectives. The first objective is to examine the cognitive profile of individuals with ARFID, with a specific focus on autistic traits and cognitive flexibility, as previous research suggests potential overlaps between ARFID and neurodevelopmental conditions such as Autism Spectrum Disorders. Cognitive flexibility refers to the ability to adapt thoughts and behaviors in response to changing situations, and reduced flexibility may contribute to rigid eating patterns and food avoidance. The second objective is to explore the role of body representation (how individuals perceive and mentally represent their own body) and inhibitory control (the ability to regulate or suppress automatic responses) in shaping the cognitive and behavioral features of ARFID and other feeding and eating disorders. These processes may help distinguish ARFID from other diagnoses and clarify shared and disorder-specific mechanisms across the FED spectrum. The study involves adult participants of all genders, including individuals diagnosed with ARFID, anorexia nervosa, and bulimia nervosa, as well as healthy control participants without a history of feeding or eating disorders. This design allows meaningful comparisons between different diagnostic groups and with the general population. The main questions the study aims to answer are: Do individuals with ARFID show a distinct cognitive profile, particularly in terms of autistic traits and cognitive flexibility, compared to individuals with other feeding and eating disorders and healthy controls? How do body representation and inhibitory control contribute to differences in eating-related behaviors across feeding and eating disorders? Are there differences in brain activity associated with implicit, automatic attitudes toward food in individuals with feeding and eating disorders compared to healthy individuals? Where comparison groups are included, researchers will compare participants with ARFID, anorexia nervosa, bulimia nervosa, and healthy controls to examine differences in cognitive functioning, psychological characteristics, and neural responses related to food processing. Participants will be asked to take part in a series of non-invasive and well-established research activities, designed to be accessible and safe. These include: Completing self-report questionnaires assessing autistic traits, body image perception, and general psychological well-being; Performing computer-based tasks that assess cognitive flexibility and decision-making; Completing behavioral tasks designed to measure inhibitory control and automatic associations with food-related stimuli;

Eligibility Criteria

Inclusion Criteria: * Diagnosis of a Feeding and Eating Disorder (ARFID, anorexia nervosa, or bulimia nervosa); * Patients of both sexes; * Age between 14 and 65 years; * Confirmed diagnosis of a Feeding and Eating Disorder; * Body Mass Index (BMI) \< 25; * Signed informed consent form for participation in the study. Exclusion Criteria: * Diagnosis of Bipolar Disorder according to DSM-5-TR criteria; * Diagnosis of a Schizophrenia Spectrum Disorder according to DSM-5-TR criteria; * Intellectual disability according to DSM-5-TR criteria; * Presence of brain tumors; * History of seizure events; * Presence of other moderate to severe neurological disorders; * Lack of the patient's consent to voluntary participation in the study; * Lack of parental or legal guardian consent for participation of a minor in the study.

Contact & Investigator

Central Contact

Giulia Mattavelli, Associated prof., researcher

✉ giulia.mattavelli@iusspavia.it

📞 +39 3397893500

Frequently Asked Questions

Who can join the NCT07478510 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 65 Years, studying ARFID. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07478510 currently recruiting?

Yes, NCT07478510 is actively recruiting participants. Contact the research team at giulia.mattavelli@iusspavia.it for enrollment information.

Where is the NCT07478510 trial being conducted?

This trial is being conducted at Pavia, Italy, Milan, Italy, Milan, Italy.

Who is sponsoring the NCT07478510 clinical trial?

NCT07478510 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology